Articles tagged with Neurodegenerative Diseases
Researchers developed novel nanoparticles that deliver RNA to microglia immune cells, reducing inflammation linked to Alzheimer's disease. The study showed a 42% reduction of PU-1 expression and multiple inflammatory markers in human cell cultures and mice models.
Researchers from SFU and UBC introduce MCS-DETECT, an AI-driven algorithm that detects membrane contact sites in large microscopy volumes without segmentation. This innovation enhances super-resolution microscopy capabilities, contributing to a better understanding of cellular interactions and complex diseases.
Researchers at Helmholtz Munich have identified a new source of stem cells in the brains of patients with brain injuries, which could lead to improved treatments for neurological disorders. The discovery involves specific astrocyte cells that exhibit properties of neural stem cells and can be regulated by a protein called Galectin 3.
A protein called TAF15 forms amyloid filaments in brain cells, affecting frontal and temporal lobes. This discovery identifies a potential target for diagnostic and therapeutic strategies for frontotemporal dementia.
Researchers have identified a new protein, TAF15, associated with frontotemporal dementia, a rare and debilitating condition. The discovery provides a potential therapeutic target for diagnostic tests and treatments, offering hope for patients and families affected by the disease.
Researchers discovered that prion protein and copper form sticky droplets under oxidative stress, leading to abnormal solid formation. The study highlights the biological significance of liquid-liquid phase separation in regulating copper homeostasis by PrP.
A new paper reveals that media coverage of Bruce Willis' condition was inaccurate, with journalists misrepresenting the relationship between aphasia and frontotemporal degeneration. The disease was often described as if it were a separate disorder from aphasia, when in fact aphasia is a symptom of frontotemporal degeneration.
Researchers found an inverse relationship between axon loss and demyelination, suggesting that 'bad' myelin can be more damaging than its absence. This study identifies potential therapeutic targets for diseases associated with myelin defects and inflammation in the nervous system.
Research reveals that brain inflammation is the primary cause of neuropsychiatric symptoms in Alzheimer's disease, including irritability, agitation, and anxiety. The study found a strong association between microglial activation and neuropsychiatric symptom severity, suggesting new pathways for therapy development.
UTEP researchers develop a therapy based on caffeic-acid derived from spent coffee grounds to protect brain cells from damage. The treatment has potential to prevent neurodegenerative disorders such as Alzheimer's and Parkinson's by removing free radicals and inhibiting amyloid protein aggregation.
Researchers at the University of Wisconsin-Madison have successfully generated human norepinephrine neurons from stem cells using a key protein called ACTIVIN-A. These LC-NE neurons may serve as models for disease in humans, enabling scientists to screen drugs and answer questions about neurodegeneration.
A new study reveals that a genetic mutation in microglia can elevate Alzheimer's risk by reducing brain circuit connections, promoting inflammation, and impairing debris clearance. The mutation affects the TREM2 protein, leading to increased expression of inflammatory genes and impaired response to neuron injury.
Dr. Sabine Krabbe is investigating the function of the brain's emotion center in neurodegenerative diseases like Alzheimer's and Parkinson's, which often co-occur with depression and anxiety. Her research aims to find common mechanisms that could lead to better treatments for patients.
Researchers have identified a crucial biological trigger of Huntington's disease, finding that methylation converts an important protein into waste. By targeting this process, they may develop effective therapies for other neurodegenerative diseases.
Dr. Vidhya Rangaraju has received a $1.2 million grant from the Chan Zuckerberg Initiative to investigate disrupted energy supply in neurons causing cognitive decline in ALS. Her lab will use super-resolution microscopy and biosensors to study metabolic disruptions in ALS.
Scientists identify pyroglutamination, a spontaneous chemical change, in peptide synthesis, leading to an amyloidal structure and potential implications for neurodegenerative diseases like Alzheimer's and Parkinson's. The process favors aggregation of molecules, forming plaques that interrupt neuronal flow.
A new study finds that dementia incidence started to increase in England and Wales after 2008, leading to a projected increase of 40% by 2040. The number of people with dementia may reach 1.7 million, twice the current estimate of one million.
Researchers at Gladstone Institutes found that ApoE4-producing neurons release HMGB1, triggering microglial activation and neurodegeneration. Blocking HMGB1 with experimental drugs offers strong protection against APOE4-driven neurodegeneration.
A recent study found a compelling link between vitamin B12 deficiency and chronic inflammation, which can lead to various health problems. The research revealed an inverse relationship between vitamin B12 levels and inflammatory markers in humans and mice, suggesting that higher vitamin B12 levels may lower inflammatory markers.
Researchers have discovered new insights into microglia-astrocyte communication and its impact on intracerebral hemorrhage, as well as the testicular toxicity of triptolide. Additionally, a study on epicardial cells has identified key gene markers associated with cardiac regenerative therapy strategies.
Cells employ a protective mechanism to preserve orphan ribosomal proteins during heat shock, allowing for rapid recovery once the stress subsides. This study uses lattice light sheet 4D imaging and pulse labeling with HaloTag dye to visualize these processes in real-time.
A new national ALS research consortium, Access for All in ALS, has been launched with a $16.7 million NIH award. The consortium will include 34 clinical sites nationwide and generate a longitudinal biorepository linked to detailed clinical information.
Researchers found that former football players with medical and mental health conditions like depression and anxiety are at higher risk of receiving an unverified CTE diagnosis. The study highlights the need for accurate diagnoses and access to proven treatments.
Researchers at Chalmers University of Technology have shown that graphene oxide nanoflakes can reduce the accumulation of misfolded amyloid peptides in yeast cells, which are similar to human neurons affected by Alzheimer's disease. This suggests that graphene oxide may hold great potential for treating neurodegenerative diseases.
A research team has identified a link between calcium imbalances and the progression of brain damage in children with rare genetic conditions. They found that stabilizing calcium levels could be a target for new treatments to prevent further deterioration.
Researchers at UB discover that neuron-derived extracellular vesicles regulate synaptic plasticity and neuronal signalling pathways in neurodegenerative diseases. The study suggests using these vesicles as a potential treatment to reverse neurodegenerative traits.
The journal highlights the complexities of neurological injury and neurodegenerative diseases, emphasizing virtual care as a potential solution. Identifying and treating neuropsychiatric symptoms is crucial for effective rehabilitation.
Researchers identified potential therapeutic targets for Alzheimer's disease and other conditions using a new approach combining AI-driven target identification with protein phase separation analysis. The study provides insights into the role of protein phase separation in human disease and its potential as a therapeutic target.
A new three-year grant will provide specialized dementia services and supports to underserved communities in Broward County. The project aims to improve quality of life for individuals living with or at risk of Alzheimer's disease, as well as their family caregivers.
The NY Genome Center will use patient-derived stem cells models combined with functional genomics and genome engineering to shed light on the biological processes underlying bipolar disorder. The study aims to address gaps in knowledge of genetic risk for bipolar disorder and advance treatment strategies.
The new guidelines provide a framework for genetic testing and counseling, recommending comprehensive testing and gene-targeted therapies for all persons with ALS. The guidelines aim to improve access and standardize practice among neurologists and genetic counselors.
A study published by UCI researchers found that N-acetylglucosamine reduced multiple inflammation and neurodegeneration markers in patients with Multiple Sclerosis. The dietary supplement also improved neurological function in 30% of patients, suggesting a potential new treatment for the condition.
Researchers unveil a groundbreaking MRI technology that non-invasively assesses brain iron homeostasis, shedding light on its role in normal brain function, aging, and disease. The technology offers sensitivity to changes in iron mobilization capacity and can differentiate between tumor tissue and healthy tissue.
A study published in EMBO Molecular Medicine has identified the cellular processes that lead to Parkinson's disease in patients with CHCHD2 gene mutations. The research found that a specific protein, casein kinase 1 epsilon/delta (Csnk1e/d), plays a crucial role in the disease's pathogenesis.
A new AI tool assesses motor performance using finger taps, providing rapid and standardized ratings, comparable to expert neurologists. The test outperformed primary care physicians in accuracy, opening doors to evaluating other movement disorders.
Researchers at Tokyo Medical and Dental University found that mutant α-synuclein protein propagates through the brain's lymphatic system in its monomeric state before aggregating, shedding light on Parkinson's disease progression. The study suggests targeting early events may limit disease progression.
Researchers developed a new model of hereditary Alzheimer's disease in marmosets by introducing mutations into the PSEN1 gene, which causes early-onset disease in humans. The study aims to characterize and validate genetic, molecular, functional, and cognitive features of aging and Alzheimer's disease in these animals.
Scientists at CU Anschutz Medical Campus discover that long-term potentiation requires structural functions of CaMKII, not enzymatic actions. This breakthrough opens the door to therapeutic use of inhibitors targeting only CaMKII activity.
A new molecule called A11 has been found to reduce inflammation and improve memory in models of Alzheimer's disease. By targeting the genetic transcription factor PU.1, A11 suppresses inflammatory gene expression in microglia immune cells, leading to reduced neurodegeneration and improved cognition.
Researchers at the University of Sydney have developed a nanoscale optical technique to monitor protein aggregates forming in cells, which can lead to neurodegenerative diseases such as Alzheimer's and ALS. The study provides a new window into the transition of proteins from liquid to solid phase.
Scientists successfully transfer a longevity gene from naked mole rats to mice, resulting in improved health and a 4.4% increase in median lifespan. The gene enhances cellular repair and protection, reducing inflammation and cancer risk, paving the way for potential human longevity benefits.
A new study by UC San Diego researchers shows that time-restricted feeding can improve memory and reduce amyloid protein accumulation in mice with Alzheimer's disease. This approach may provide a simple and accessible way to correct circadian disruptions, which are the leading cause of nursing home placement.
A Northwestern University study reveals how the NEK1 gene mutation affects neurons, causing instability in microtubules and disrupting nuclear import. This discovery suggests anti-cancer drugs could be used to treat ALS by stabilizing microtubules.
Researchers at UC San Diego demonstrate that hematopoietic stem cell transplants can protect against multiple signs and symptoms of Alzheimer's in a mouse model of the disease. The therapy leads to enhanced microglia health, which protects against Alzheimer's pathology, including β-amyloid build-up and neuroinflammation.
Researchers at the University of Missouri have developed a new method using nanopores to advance discoveries in neuroscience and medical applications. The technique allows for real-time detection of dynamic aptamer-small molecule interactions, which can aid in understanding DNA and RNA diseases and drug discovery.
Researchers at Scripps Research have identified a unique mitochondrial protein structure, DELE1, that plays a crucial role in activating the cell's integrated stress response. This discovery could lead to the development of new therapies for age-related diseases such as neurodegeneration and cancer.
A recent study found that the cGAS/STING molecular signaling pathway plays a critical role in driving chronic inflammation and functional decline during aging. By blocking STING, researchers were able to suppress inflammatory responses and improve tissue function, leading to enhancements in spatial and associative memory.
Scientists develop a method to construct crystalline artificial steric zippers in peptide β-sheets, paving the way for novel therapeutic strategies and materials. The research utilizes metal ions to prevent aggregation and form needle-shaped crystals with specific structural characteristics.
TRIM11 protein levels decreased in Alzheimer's disease models, suggesting replenishment may improve cognitive and motor function. The study reveals that TRIM11 plays a key role in removing tau protein tangles that cause neurodegenerative diseases like AD.
Researchers from Sahmyook University found that phyllodulcin, a natural sweetener found in hydrangeas, can efficiently inhibit amyloid beta (Aβ) aggregation and dissociate its aggregates in an animal model study. The study suggests that phyllodulcin may be useful in delaying the onset and progression of Alzheimer's disease.
Researchers at the University of Virginia Health System discovered that improper calcium signaling in mitochondria accelerates chronic inflammation, leading to age-related conditions. Increasing calcium uptake in macrophages may help prevent harmful inflammation and its effects on the brain.
A new study suggests that incorporating olive oil into your diet could help reduce the risk of dying from dementia. Regular olive oil consumption was found to be associated with a 28% lower risk of fatal dementia compared to those who never or rarely consumed olive oil.
A new diet score reveals that people who follow a more sustainable diet are 25% less likely to die during a 30-year follow-up period. Plant-based foods are associated with lower risks of chronic diseases and reduced environmental impacts.
A study published in Neuron reveals that hundreds of proteins and mRNA molecules are found in the wrong place in nerve cells affected by Motor Neurone Disease, a condition that causes paralysis. The researchers found that mislocalisation affects many more proteins than first thought, especially those involved in RNA binding.
A new study published in Aging (Albany NY) suggests that prior training can rescue cognitive decline in aging by improving task performance and strengthening memory processes. The research, conducted on rats, found that prior training enhanced short-term and intermediate memory, while also enabling encoding-boosted long-term memory.
The new Clinical Research Unit will investigate autoantibodies' role in neurological disorders, focusing on diagnosis and treatment. Researchers expect innovative therapies for patients with previously suspected diseases.
Researchers have successfully visualized the three-dimensional structure of human tRNA splicing endonuclease TSEN, a crucial enzyme in tRNA maturation. The study reveals how TSEN recognizes and excises introns from precursor tRNAs, shedding light on its role in neurodegenerative disorders like pontocerebellar hypoplasia.
Researchers discovered that CLN3 is essential for lysosome biogenesis and autophagic lysosomal reformation (ALR), uncovering a novel disease mechanism in Batten disease. The loss of CLN3 impairs lysosome formation, leading to the accumulation of dysfunctional lysosomes.
ClearTau overcomes limitations of previous methods by producing Tau fibrils efficiently and consistently. This allows researchers to study the development of tauopathies and develop disease-specific therapeutics.
A new study describes an engineered approach that makes protein aggregates amenable to spatial manipulations in both budding yeast and human cells. This system allows for the export of protein aggregates from cells, potentially protecting mother cells from toxicity and contributing to a better understanding of neurodegenerative diseases.